Global Hypertension Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Hypertension Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Hypertension Drug Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Calcium Channel Blockers
1.2.3 Diuretics
1.2.4 Beta Blockers Vasodilators
1.2.5 Angiotensin Converting Enzyme Inhibitors
1.2.6 Alpha Blockers
1.2.7 Angiotensin Receptor Blockers
1.2.8 Renin Inhibitors
1.3 Market Segment by Application
1.3.1 Global Hypertension Drug Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Private Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Hypertension Drug Market Size (2017-2028)
2.1.1 Global Hypertension Drug Revenue (2017-2028)
2.1.2 Global Hypertension Drug Sales (2017-2028)
2.2 Global Hypertension Drug Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Hypertension Drug Sales by Regions (2017-2022)
2.2.2 Global Hypertension Drug Revenue by Regions (2017-2022)
2.3 Global Hypertension Drug Market Size Forecast by Region
2.3.1 Global Hypertension Drug Sales Forecast by Region (2023-2028)
2.3.2 Global Hypertension Drug Revenue Forecast by Region (2023-2028)
2.4 Global Top Hypertension Drug Regions (Countries) Ranking by Market Size
2.5 Hypertension Drug Market Dynamics
2.5.1 Hypertension Drug Market Trends
2.5.2 Hypertension Drug Market Drivers
2.5.3 Hypertension Drug Market Challenges
2.5.4 Hypertension Drug Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Hypertension Drug Manufacturers by Sales (2017-2022)
3.1.1 Global Hypertension Drug Sales by Manufacturers (2017-2022)
3.1.2 Global Hypertension Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Hypertension Drug Sales in 2021
3.2 Global Top Manufacturers Hypertension Drug by Revenue
3.2.1 Global Hypertension Drug Revenue by Manufacturers (2017-2022)
3.2.2 Top Hypertension Drug Manufacturers Covered: Ranking by Revenue
3.2.3 Global Hypertension Drug Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Hypertension Drug Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hypertension Drug as of 2021)
3.4 Global Hypertension Drug Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Hypertension Drug Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Hypertension Drug Market
3.7 Key Manufacturers Hypertension Drug Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Hypertension Drug Market Size by Type
4.1 Global Hypertension Drug Historic Market Review by Type (2017-2022)
4.1.1 Global Hypertension Drug Sales Market Share by Type (2017-2022)
4.1.2 Global Hypertension Drug Revenue Market Share by Type (2017-2022)
4.1.3 Hypertension Drug Price by Type (2017-2022)
4.2 Global Hypertension Drug Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Hypertension Drug Sales Forecast by Type (2023-2028)
4.2.2 Global Hypertension Drug Revenue Forecast by Type (2023-2028)
4.2.3 Hypertension Drug Price Forecast by Type (2023-2028)
5 Global Hypertension Drug Market Size by Application
5.1 Global Hypertension Drug Historic Market Review by Application (2017-2022)
5.1.1 Global Hypertension Drug Sales Market Share by Application (2017-2022)
5.1.2 Global Hypertension Drug Revenue Market Share by Application (2017-2022)
5.1.3 Hypertension Drug Price by Application (2017-2022)
5.2 Global Hypertension Drug Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Hypertension Drug Sales Forecast by Application (2023-2028)
5.2.2 Global Hypertension Drug Revenue Forecast by Application (2023-2028)
5.2.3 Hypertension Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hypertension Drug Sales Breakdown by Company
6.1.1 North America Hypertension Drug Sales by Company (2017-2022)
6.1.2 North America Hypertension Drug Revenue by Company (2017-2022)
6.2 North America Hypertension Drug Market Size by Type
6.2.1 North America Hypertension Drug Sales by Type (2017-2028)
6.2.2 North America Hypertension Drug Revenue by Type (2017-2028)
6.3 North America Hypertension Drug Market Size by Application
6.3.1 North America Hypertension Drug Sales by Application (2017-2028)
6.3.2 North America Hypertension Drug Revenue by Application (2017-2028)
6.4 North America Hypertension Drug Market Size by Country
6.4.1 North America Hypertension Drug Sales by Country (2017-2028)
6.4.2 North America Hypertension Drug Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Hypertension Drug Sales Breakdown by Company
7.1.1 Europe Hypertension Drug Sales by Company (2017-2022)
7.1.2 Europe Hypertension Drug Revenue by Company (2017-2022)
7.2 Europe Hypertension Drug Market Size by Type
7.2.1 Europe Hypertension Drug Sales by Type (2017-2028)
7.2.2 Europe Hypertension Drug Revenue by Type (2017-2028)
7.3 Europe Hypertension Drug Market Size by Application
7.3.1 Europe Hypertension Drug Sales by Application (2017-2028)
7.3.2 Europe Hypertension Drug Revenue by Application (2017-2028)
7.4 Europe Hypertension Drug Market Size by Country
7.4.1 Europe Hypertension Drug Sales by Country (2017-2028)
7.4.2 Europe Hypertension Drug Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hypertension Drug Sales Breakdown by Company
8.1.1 Asia Pacific Hypertension Drug Sales by Company (2017-2022)
8.1.2 Asia Pacific Hypertension Drug Revenue by Company (2017-2022)
8.2 Asia Pacific Hypertension Drug Market Size by Type
8.2.1 Asia Pacific Hypertension Drug Sales by Type (2017-2028)
8.2.2 Asia Pacific Hypertension Drug Revenue by Type (2017-2028)
8.3 Asia Pacific Hypertension Drug Market Size by Application
8.3.1 Asia Pacific Hypertension Drug Sales by Application (2017-2028)
8.3.2 Asia Pacific Hypertension Drug Revenue by Application (2017-2028)
8.4 Asia Pacific Hypertension Drug Market Size by Region
8.4.1 Asia Pacific Hypertension Drug Sales by Region
8.4.2 Asia Pacific Hypertension Drug Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Hypertension Drug Sales Breakdown by Company
9.1.1 Latin America Hypertension Drug Sales by Company (2017-2022)
9.1.2 Latin America Hypertension Drug Revenue by Company (2017-2022)
9.2 Latin America Hypertension Drug Market Size by Type
9.2.1 Latin America Hypertension Drug Sales by Type (2017-2028)
9.2.2 Latin America Hypertension Drug Revenue by Type (2017-2028)
9.3 Latin America Hypertension Drug Market Size by Application
9.3.1 Latin America Hypertension Drug Sales by Application (2017-2028)
9.3.2 Latin America Hypertension Drug Revenue by Application (2017-2028)
9.4 Latin America Hypertension Drug Market Size by Country
9.4.1 Latin America Hypertension Drug Sales by Country (2017-2028)
9.4.2 Latin America Hypertension Drug Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hypertension Drug Sales Breakdown by Company
10.1.1 Middle East and Africa Hypertension Drug Sales by Company (2017-2022)
10.1.2 Middle East and Africa Hypertension Drug Revenue by Company (2017-2022)
10.2 Middle East and Africa Hypertension Drug Market Size by Type
10.2.1 Middle East and Africa Hypertension Drug Sales by Type (2017-2028)
10.2.2 Middle East and Africa Hypertension Drug Revenue by Type (2017-2028)
10.3 Middle East and Africa Hypertension Drug Market Size by Application
10.3.1 Middle East and Africa Hypertension Drug Sales by Application (2017-2028)
10.3.2 Middle East and Africa Hypertension Drug Revenue by Application (2017-2028)
10.4 Middle East and Africa Hypertension Drug Market Size by Country
10.4.1 Middle East and Africa Hypertension Drug Sales by Country (2017-2028)
10.4.2 Middle East and Africa Hypertension Drug Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Lupin Limited
11.1.1 Lupin Limited Corporation Information
11.1.2 Lupin Limited Overview
11.1.3 Lupin Limited Hypertension Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Lupin Limited Hypertension Drug Products and Services
11.1.5 Lupin Limited Hypertension Drug SWOT Analysis
11.1.6 Lupin Limited Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Overview
11.2.3 Novartis AG Hypertension Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Novartis AG Hypertension Drug Products and Services
11.2.5 Novartis AG Hypertension Drug SWOT Analysis
11.2.6 Novartis AG Recent Developments
11.3 Daiichi - Sankyo
11.3.1 Daiichi - Sankyo Corporation Information
11.3.2 Daiichi - Sankyo Overview
11.3.3 Daiichi - Sankyo Hypertension Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Daiichi - Sankyo Hypertension Drug Products and Services
11.3.5 Daiichi - Sankyo Hypertension Drug SWOT Analysis
11.3.6 Daiichi - Sankyo Recent Developments
11.4 Pfizer Inc
11.4.1 Pfizer Inc Corporation Information
11.4.2 Pfizer Inc Overview
11.4.3 Pfizer Inc Hypertension Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Pfizer Inc Hypertension Drug Products and Services
11.4.5 Pfizer Inc Hypertension Drug SWOT Analysis
11.4.6 Pfizer Inc Recent Developments
11.5 Ranbaxy Laboratories Limited
11.5.1 Ranbaxy Laboratories Limited Corporation Information
11.5.2 Ranbaxy Laboratories Limited Overview
11.5.3 Ranbaxy Laboratories Limited Hypertension Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Ranbaxy Laboratories Limited Hypertension Drug Products and Services
11.5.5 Ranbaxy Laboratories Limited Hypertension Drug SWOT Analysis
11.5.6 Ranbaxy Laboratories Limited Recent Developments
11.6 Sanofi S.A
11.6.1 Sanofi S.A Corporation Information
11.6.2 Sanofi S.A Overview
11.6.3 Sanofi S.A Hypertension Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Sanofi S.A Hypertension Drug Products and Services
11.6.5 Sanofi S.A Hypertension Drug SWOT Analysis
11.6.6 Sanofi S.A Recent Developments
11.7 AstraZeneca Plc
11.7.1 AstraZeneca Plc Corporation Information
11.7.2 AstraZeneca Plc Overview
11.7.3 AstraZeneca Plc Hypertension Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 AstraZeneca Plc Hypertension Drug Products and Services
11.7.5 AstraZeneca Plc Hypertension Drug SWOT Analysis
11.7.6 AstraZeneca Plc Recent Developments
11.8 Johnson & Johnson Ltd
11.8.1 Johnson & Johnson Ltd Corporation Information
11.8.2 Johnson & Johnson Ltd Overview
11.8.3 Johnson & Johnson Ltd Hypertension Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Johnson & Johnson Ltd Hypertension Drug Products and Services
11.8.5 Johnson & Johnson Ltd Hypertension Drug SWOT Analysis
11.8.6 Johnson & Johnson Ltd Recent Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Overview
11.9.3 Boehringer Ingelheim Hypertension Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Boehringer Ingelheim Hypertension Drug Products and Services
11.9.5 Boehringer Ingelheim Hypertension Drug SWOT Analysis
11.9.6 Boehringer Ingelheim Recent Developments
11.10 Merck & Co.
11.10.1 Merck & Co. Corporation Information
11.10.2 Merck & Co. Overview
11.10.3 Merck & Co. Hypertension Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Merck & Co. Hypertension Drug Products and Services
11.10.5 Merck & Co. Hypertension Drug SWOT Analysis
11.10.6 Merck & Co. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Hypertension Drug Value Chain Analysis
12.2 Hypertension Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hypertension Drug Production Mode & Process
12.4 Hypertension Drug Sales and Marketing
12.4.1 Hypertension Drug Sales Channels
12.4.2 Hypertension Drug Distributors
12.5 Hypertension Drug Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Hypertension Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Calcium Channel Blockers
Table 3. Major Manufacturers of Diuretics
Table 4. Major Manufacturers of Beta Blockers Vasodilators
Table 5. Major Manufacturers of Angiotensin Converting Enzyme Inhibitors
Table 6. Major Manufacturers of Alpha Blockers
Table 7. Major Manufacturers of Angiotensin Receptor Blockers
Table 8. Major Manufacturers of Renin Inhibitors
Table 9. Global Hypertension Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Hypertension Drug Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 11. Global Hypertension Drug Sales by Region (2017-2022) & (K Units)
Table 12. Global Hypertension Drug Sales Market Share by Region (2017-2022)
Table 13. Global Hypertension Drug Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Hypertension Drug Revenue Market Share by Region (2017-2022)
Table 15. Global Hypertension Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 16. Global Hypertension Drug Sales Market Share Forecast by Region (2023-2028)
Table 17. Global Hypertension Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 18. Global Hypertension Drug Revenue Market Share Forecast by Region (2023-2028)
Table 19. Top Hypertension Drug Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 20. Hypertension Drug Market Trends
Table 21. Hypertension Drug Market Drivers
Table 22. Hypertension Drug Market Challenges
Table 23. Hypertension Drug Market Restraints
Table 24. Global Hypertension Drug Sales by Manufacturers (2017-2022) & (K Units)
Table 25. Global Hypertension Drug Sales Share by Manufacturers (2017-2022)
Table 26. Global Hypertension Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 27. Ranking of Global Top Hypertension Drug Manufacturers by Revenue (US$ Million) in 2021
Table 28. Hypertension Drug Revenue Share by Manufacturers (2017-2022)
Table 29. Global Hypertension Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hypertension Drug as of 2021)
Table 31. Key Manufacturers Hypertension Drug Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 32. Key Manufacturers Hypertension Drug Plants/Factories Distribution
Table 33. Key Manufacturers Hypertension Drug Area Served
Table 34. Date of Key Manufacturers Enter into Hypertension Drug Market
Table 35. Key Manufacturers Hypertension Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Hypertension Drug Sales (K Units) by Type (2017-2022)
Table 38. Global Hypertension Drug Sales Share by Type (2017-2022)
Table 39. Global Hypertension Drug Revenue (US$ Million) Market Share by Type (2017-2022)
Table 40. Global Hypertension Drug Price (K Units) by Type (2017-2022)
Table 41. Global Hypertension Drug Sales (K Units) by Type (2023-2028)
Table 42. Global Hypertension Drug Sales Share by Type (2023-2028)
Table 43. Global Hypertension Drug Revenue (US$ Million) Market Share by Type (2023-2028)
Table 44. Global Hypertension Drug Revenue Share by Type (2023-2028)
Table 45. Global Hypertension Drug Price (K Units) by Type (2023-2028)
Table 46. Global Hypertension Drug Sales (K Units) by Application (2017-2022)
Table 47. Global Hypertension Drug Sales Share by Application (2017-2022)
Table 48. Global Hypertension Drug Revenue (US$ Million) Market Share by Application (2017-2022)
Table 49. Global Hypertension Drug Price (K Units) by Application (2017-2022)
Table 50. Global Hypertension Drug Sales (K Units) by Application (2023-2028)
Table 51. Global Hypertension Drug Sales Share by Application (2023-2028)
Table 52. Global Hypertension Drug Revenue (US$ Million) Market Share by Application (2023-2028)
Table 53. Global Hypertension Drug Revenue Share by Application (2023-2028)
Table 54. Global Hypertension Drug Price (K Units) by Application (2023-2028)
Table 55. North America Hypertension Drug Sales by Company (2017-2022) & (K Units)
Table 56. North America Hypertension Drug Sales Market Share by Company (2017-2022)
Table 57. North America Hypertension Drug Revenue by Company (2017-2022) & (US$ Million)
Table 58. North America Hypertension Drug Revenue Market Share by Company (2017-2022)
Table 59. North America Hypertension Drug Sales by Type (2017-2022) & (K Units)
Table 60. North America Hypertension Drug Sales by Type (2023-2028) & (K Units)
Table 61. North America Hypertension Drug Revenue by Type (2017-2022) & (US$ Million)
Table 62. North America Hypertension Drug Revenue by Type (2023-2028) & (US$ Million)
Table 63. North America Hypertension Drug Sales by Application (2017-2022) & (K Units)
Table 64. North America Hypertension Drug Sales by Application (2023-2028) & (K Units)
Table 65. North America Hypertension Drug Revenue by Application (2017-2022) & (US$ Million)
Table 66. North America Hypertension Drug Revenue by Application (2023-2028) & (US$ Million)
Table 67. North America Hypertension Drug Sales by Country (2017-2022) & (K Units)
Table 68. North America Hypertension Drug Sales by Country (2023-2028) & (K Units)
Table 69. North America Hypertension Drug Revenue by Country (2017-2022) & (US$ Million)
Table 70. North America Hypertension Drug Revenue by Country (2023-2028) & (US$ Million)
Table 71. Europe Hypertension Drug Sales by Company (2017-2022) & (K Units)
Table 72. Europe Hypertension Drug Sales Market Share by Company (2017-2022)
Table 73. Europe Hypertension Drug Revenue by Company (2017-2022) & (US$ Million)
Table 74. Europe Hypertension Drug Revenue Market Share by Company (2017-2022)
Table 75. Europe Hypertension Drug Sales by Type (2017-2022) & (K Units)
Table 76. Europe Hypertension Drug Sales by Type (2023-2028) & (K Units)
Table 77. Europe Hypertension Drug Revenue by Type (2017-2022) & (US$ Million)
Table 78. Europe Hypertension Drug Revenue by Type (2023-2028) & (US$ Million)
Table 79. Europe Hypertension Drug Sales by Application (2017-2022) & (K Units)
Table 80. Europe Hypertension Drug Sales by Application (2023-2028) & (K Units)
Table 81. Europe Hypertension Drug Revenue by Application (2017-2022) & (US$ Million)
Table 82. Europe Hypertension Drug Revenue by Application (2023-2028) & (US$ Million)
Table 83. Europe Hypertension Drug Sales by Country (2017-2022) & (K Units)
Table 84. Europe Hypertension Drug Sales by Country (2023-2028) & (K Units)
Table 85. Europe Hypertension Drug Revenue by Country (2017-2022) & (US$ Million)
Table 86. Europe Hypertension Drug Revenue by Country (2023-2028) & (US$ Million)
Table 87. Asia Pacific Hypertension Drug Sales by Company (2017-2022) & (K Units)
Table 88. Asia Pacific Hypertension Drug Sales Market Share by Company (2017-2022)
Table 89. Asia Pacific Hypertension Drug Revenue by Company (2017-2022) & (US$ Million)
Table 90. Asia Pacific Hypertension Drug Revenue Market Share by Company (2017-2022)
Table 91. Asia Pacific Hypertension Drug Sales by Type (2017-2022) & (K Units)
Table 92. Asia Pacific Hypertension Drug Sales by Type (2023-2028) & (K Units)
Table 93. Asia Pacific Hypertension Drug Revenue by Type (2017-2022) & (US$ Million)
Table 94. Asia Pacific Hypertension Drug Revenue by Type (2023-2028) & (US$ Million)
Table 95. Asia Pacific Hypertension Drug Sales by Application (2017-2022) & (K Units)
Table 96. Asia Pacific Hypertension Drug Sales by Application (2023-2028) & (K Units)
Table 97. Asia Pacific Hypertension Drug Revenue by Application (2017-2022) & (US$ Million)
Table 98. Asia Pacific Hypertension Drug Revenue by Application (2023-2028) & (US$ Million)
Table 99. Asia Pacific Hypertension Drug Sales by Region (2017-2022) & (K Units)
Table 100. Asia Pacific Hypertension Drug Sales by Region (2023-2028) & (K Units)
Table 101. Asia Pacific Hypertension Drug Revenue by Region (2017-2022) & (US$ Million)
Table 102. Asia Pacific Hypertension Drug Revenue by Region (2023-2028) & (US$ Million)
Table 103. Latin America Hypertension Drug Sales by Company (2017-2022) & (K Units)
Table 104. Latin America Hypertension Drug Sales Market Share by Company (2017-2022)
Table 105. Latin America Hypertension Drug Revenue by Company (2017-2022) & (US$ Million)
Table 106. Latin America Hypertension Drug Revenue Market Share by Company (2017-2022)
Table 107. Latin America Hypertension Drug Sales by Type (2017-2022) & (K Units)
Table 108. Latin America Hypertension Drug Sales by Type (2023-2028) & (K Units)
Table 109. Latin America Hypertension Drug Revenue by Type (2017-2022) & (US$ Million)
Table 110. Latin America Hypertension Drug Revenue by Type (2023-2028) & (US$ Million)
Table 111. Latin America Hypertension Drug Sales by Application (2017-2022) & (K Units)
Table 112. Latin America Hypertension Drug Sales by Application (2023-2028) & (K Units)
Table 113. Latin America Hypertension Drug Revenue by Application (2017-2022) & (US$ Million)
Table 114. Latin America Hypertension Drug Revenue by Application (2023-2028) & (US$ Million)
Table 115. Latin America Hypertension Drug Sales by Country (2017-2022) & (K Units)
Table 116. Latin America Hypertension Drug Sales by Country (2023-2028) & (K Units)
Table 117. Latin America Hypertension Drug Revenue by Country (2017-2022) & (US$ Million)
Table 118. Latin America Hypertension Drug Revenue by Country (2023-2028) & (US$ Million)
Table 119. Middle East and Africa Hypertension Drug Sales by Company (2017-2022) & (K Units)
Table 120. Middle East and Africa Hypertension Drug Sales Market Share by Company (2017-2022)
Table 121. Middle East and Africa Hypertension Drug Revenue by Company (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Hypertension Drug Revenue Market Share by Company (2017-2022)
Table 123. Middle East and Africa Hypertension Drug Sales by Type (2017-2022) & (K Units)
Table 124. Middle East and Africa Hypertension Drug Sales by Type (2023-2028) & (K Units)
Table 125. Middle East and Africa Hypertension Drug Revenue by Type (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Hypertension Drug Revenue by Type (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Hypertension Drug Sales by Application (2017-2022) & (K Units)
Table 128. Middle East and Africa Hypertension Drug Sales by Application (2023-2028) & (K Units)
Table 129. Middle East and Africa Hypertension Drug Revenue by Application (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Hypertension Drug Revenue by Application (2023-2028) & (US$ Million)
Table 131. Middle East and Africa Hypertension Drug Sales by Country (2017-2022) & (K Units)
Table 132. Middle East and Africa Hypertension Drug Sales by Country (2023-2028) & (K Units)
Table 133. Middle East and Africa Hypertension Drug Revenue by Country (2017-2022) & (US$ Million)
Table 134. Middle East and Africa Hypertension Drug Revenue by Country (2023-2028) & (US$ Million)
Table 135. Lupin Limited Corporation Information
Table 136. Lupin Limited Description and Overview
Table 137. Lupin Limited Hypertension Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 138. Lupin Limited Hypertension Drug Product and Services
Table 139. Lupin Limited Hypertension Drug SWOT Analysis
Table 140. Lupin Limited Recent Developments
Table 141. Novartis AG Corporation Information
Table 142. Novartis AG Description and Overview
Table 143. Novartis AG Hypertension Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 144. Novartis AG Hypertension Drug Product and Services
Table 145. Novartis AG Hypertension Drug SWOT Analysis
Table 146. Novartis AG Recent Developments
Table 147. Daiichi - Sankyo Corporation Information
Table 148. Daiichi - Sankyo Description and Overview
Table 149. Daiichi - Sankyo Hypertension Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 150. Daiichi - Sankyo Hypertension Drug Product and Services
Table 151. Daiichi - Sankyo Hypertension Drug SWOT Analysis
Table 152. Daiichi - Sankyo Recent Developments
Table 153. Pfizer Inc Corporation Information
Table 154. Pfizer Inc Description and Overview
Table 155. Pfizer Inc Hypertension Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 156. Pfizer Inc Hypertension Drug Product and Services
Table 157. Pfizer Inc Hypertension Drug SWOT Analysis
Table 158. Pfizer Inc Recent Developments
Table 159. Ranbaxy Laboratories Limited Corporation Information
Table 160. Ranbaxy Laboratories Limited Description and Overview
Table 161. Ranbaxy Laboratories Limited Hypertension Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 162. Ranbaxy Laboratories Limited Hypertension Drug Product and Services
Table 163. Ranbaxy Laboratories Limited Hypertension Drug SWOT Analysis
Table 164. Ranbaxy Laboratories Limited Recent Developments
Table 165. Sanofi S.A Corporation Information
Table 166. Sanofi S.A Description and Overview
Table 167. Sanofi S.A Hypertension Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 168. Sanofi S.A Hypertension Drug Product and Services
Table 169. Sanofi S.A Hypertension Drug SWOT Analysis
Table 170. Sanofi S.A Recent Developments
Table 171. AstraZeneca Plc Corporation Information
Table 172. AstraZeneca Plc Description and Overview
Table 173. AstraZeneca Plc Hypertension Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 174. AstraZeneca Plc Hypertension Drug Product and Services
Table 175. AstraZeneca Plc Hypertension Drug SWOT Analysis
Table 176. AstraZeneca Plc Recent Developments
Table 177. Johnson & Johnson Ltd Corporation Information
Table 178. Johnson & Johnson Ltd Description and Overview
Table 179. Johnson & Johnson Ltd Hypertension Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 180. Johnson & Johnson Ltd Hypertension Drug Product and Services
Table 181. Johnson & Johnson Ltd Hypertension Drug SWOT Analysis
Table 182. Johnson & Johnson Ltd Recent Developments
Table 183. Boehringer Ingelheim Corporation Information
Table 184. Boehringer Ingelheim Description and Overview
Table 185. Boehringer Ingelheim Hypertension Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 186. Boehringer Ingelheim Hypertension Drug Product and Services
Table 187. Boehringer Ingelheim Hypertension Drug SWOT Analysis
Table 188. Boehringer Ingelheim Recent Developments
Table 189. Merck & Co. Corporation Information
Table 190. Merck & Co. Description and Overview
Table 191. Merck & Co. Hypertension Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 192. Merck & Co. Hypertension Drug Product and Services
Table 193. Merck & Co. Hypertension Drug SWOT Analysis
Table 194. Merck & Co. Recent Developments
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Hypertension Drug Distributors List
Table 198. Hypertension Drug Customers List
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. Hypertension Drug Product Picture
Figure 2. Global Hypertension Drug Sales Market Share by Type in 2021 & 2028
Figure 3. Calcium Channel Blockers Product Picture
Figure 4. Diuretics Product Picture
Figure 5. Beta Blockers Vasodilators Product Picture
Figure 6. Angiotensin Converting Enzyme Inhibitors Product Picture
Figure 7. Alpha Blockers Product Picture
Figure 8. Angiotensin Receptor Blockers Product Picture
Figure 9. Renin Inhibitors Product Picture
Figure 10. Global Hypertension Drug Sales Market Share by Application in 2021 & 2028
Figure 11. Hospital Use Case
Figure 12. Private Clinic Use Case
Figure 13. Others Use Case
Figure 14. Hypertension Drug Report Years Considered
Figure 15. Global Hypertension Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Hypertension Drug Market Size 2017-2028 (US$ Million)
Figure 17. Global Hypertension Drug Sales (2017-2022) & (K Units)
Figure 18. Global Hypertension Drug Market Size Market Share by Region: 2021 VS 2028
Figure 19. Global Hypertension Drug Sales Market Share by Region (2017-2022)
Figure 20. Global Hypertension Drug Sales Market Share by Region in 2021
Figure 21. Global Hypertension Drug Revenue Market Share by Region in 2017 VS 2021
Figure 22. Global Hypertension Drug Sales Share by Manufacturers in 2021
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Hypertension Drug Sales in 2021
Figure 24. Hypertension Drug Revenue Share by Manufacturers in 2021
Figure 25. Hypertension Drug Market Share by Company Type (Tier 1

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......

Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......

Global Amlodipine Besylate Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115

The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......

Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112

The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......

Captopril API - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100

The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Telmisartan - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107

The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......

Global Ambrisentan Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Ambrisentan Market Research Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs